Home
Placeholder for missing image of Xiongyu Wu

Xiongyu Wu

Principal Research Engineer

Förste forskningsingenjör

Publications

2025

Jiwen Hu, Hong Wang, Xin Zhang, Chunfei Wang, Anna Du Rietz, Mengtao Rong, Caroline Brommesson, Xiongyu Wu, Zhanxiao Wei, Ruilong Zhang, Xuanjun Zhang, Kajsa Uvdal, Zhang-Jun Hu (2025) Real-Time Monitoring of Adenosine Triphosphate Fluctuation in Lysosome during Autophagy/Mitophagy ACS Applied Materials and Interfaces, Vol. 17, p. 41719-41728 (Article in journal) Continue to DOI
Jiwen Hu, Hong Wang, Xin Zhang, Chunfei Wang, Anna du Rietz, Mengtao Rong, Caroline Brommesson, Xiongyu Wu, Zhanxiao Wei, Ruilong Zhang, Xuanjun Zhang, Kajsa Uvdal, Zhangjun Hu (2025) Real-Time Monitoring of Adenosine Triphosphate Fluctuation in Lysosome during Autophagy/Mitophagy ACS Applied Materials and Interfaces, Vol. 17, p. 41719-41728 (Article in journal) Continue to DOI
Steven R. Baginski, Karin Lindbom, Bryan Valencia Crespo, Ghidaa Bessa, Tobias Rautio, Xiongyu Wu, Johan Dahlén, Lorna A. Nisbet, Craig McKenzie, Henrik Green (2025) Structure-metabolism relationships of 4-pentenyl synthetic cannabinoid receptor agonists using in vitro human hepatocyte incubations and high-resolution mass spectrometry Archives of Toxicology, Vol. 99, p. 3331-3341 (Article in journal) Continue to DOI
Henrik Green, Craig McKenzie, Elias Hamra, Tobias Rautio, Xiongyu Wu, Emma Juneskog, Rebecka Sandblom, Manuela Monti, Mattias Persson, Caitlyn Norman (2025) In vitro CB1 receptor activity of halogenated indazole synthetic cannabinoid receptor agonists Archives of Toxicology, Vol. 99, p. 3343-3353 (Article in journal) Continue to DOI
Tobias Rautio, Robin Obrist, Lucas Krebs, Therése Klingstedt, Johan Dahlén, Xiongyu Wu, Henrik Green (2025) In vitro metabolism study of ADB-P-5Br-INACA and ADB-4en-P-5Br-INACA using human hepatocytes, liver microsomes, and in-house synthesized references Drug Testing and Analysis, Vol. 17, p. 701-712 (Article in journal) Continue to DOI

News

Nina Ottosson in the lab.

A drug from resin to combat epileptic seizures

New molecules, developed by researchers at Linköping University, have promising properties as possible drugs against epilepsy. A study published in the journal Epilepsia shows that several of the molecules have antiseizure effects.
Female scientist lecturing.

New method to dampen nerve signals

Researchers at LiU have discovered a previously unknown molecular binding site that can influence electrical impulses in nerves. The discovery opens the possibility of designing new types of drugs against conditions such as epilepsy.

Tags